|
DK0915899T3
(da)
|
1996-07-29 |
2004-11-29 |
Abbott Lab |
Fremstilling af krystallinsk form II af clarithromycin
|
|
US5858986A
(en)
|
1996-07-29 |
1999-01-12 |
Abbott Laboratories |
Crystal form I of clarithromycin
|
|
US5945405A
(en)
|
1997-01-17 |
1999-08-31 |
Abbott Laboratories |
Crystal form O of clarithromycin
|
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
AU2274799A
(en)
*
|
1997-12-22 |
1999-07-12 |
Biochemie S.A. |
Intermediates in macrolide production
|
|
KR100283990B1
(ko)
*
|
1998-12-29 |
2001-03-02 |
민경윤 |
에리스로마이신 a 유도체 및 그의 제조방법
|
|
US6437106B1
(en)
|
1999-06-24 |
2002-08-20 |
Abbott Laboratories |
Process for preparing 6-o-substituted erythromycin derivatives
|
|
GB9915745D0
(en)
*
|
1999-07-06 |
1999-09-08 |
Biochemie Sa |
Organic compounds
|
|
YU45602A
(sh)
*
|
1999-12-16 |
2005-06-10 |
Teva Pharmaceutical Industries Ltd. |
Postupci za dobijanje polimorfa klaritromicina i novi polimorf iv
|
|
DE60018119T2
(de)
*
|
2000-01-11 |
2006-05-04 |
Teva Pharmaceutical Industries Ltd. |
Verfahren zur herstellung von polymorphen des clarithromycins
|
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
CA2401571A1
(en)
*
|
2000-02-29 |
2001-09-07 |
Ilya Avrutov |
Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
|
|
ES2242668T3
(es)
*
|
2000-03-15 |
2005-11-16 |
Hanmi Pharm. Co., Ltd. |
Metodo para obtener claritromicina en cristales de forma ii.
|
|
KR100367981B1
(ko)
*
|
2000-11-23 |
2003-01-14 |
한미약품공업 주식회사 |
클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물
|
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
|
AU2004258953B2
(en)
|
2003-07-21 |
2011-02-10 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
|
JP2006528185A
(ja)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質製剤、その使用法及び作成方法
|
|
AU2004258949B2
(en)
|
2003-07-21 |
2011-02-10 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
|
JP2007502296A
(ja)
|
2003-08-11 |
2007-02-08 |
アドバンシス ファーマスーティカル コーポレイション |
ロバストペレット
|
|
EP1653924A4
(en)
|
2003-08-12 |
2009-09-09 |
Middlebrook Pharmaceuticals In |
ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
|
|
CA2535780A1
(en)
*
|
2003-08-29 |
2005-03-17 |
Advancis Pharmaceuticals Corporation |
Antibiotic product, use and formulation thereof
|
|
CA2538064C
(en)
|
2003-09-15 |
2013-12-17 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
|
JP2008505124A
(ja)
|
2004-07-02 |
2008-02-21 |
アドバンシス ファーマスーティカル コーポレイション |
パルス送達用錠剤
|
|
US20060111560A1
(en)
*
|
2004-11-01 |
2006-05-25 |
Glenmark Pharmaceuticals Limited |
Process for the preparation of crystalline form II of clarithromycin
|
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
|
US8613920B2
(en)
|
2007-07-27 |
2013-12-24 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
US20090054634A1
(en)
*
|
2007-08-09 |
2009-02-26 |
Vinod Kumar Kansal |
Process for the preparation of clarithromycin
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|